Accueil Ernstrade Bourse Actualite Stock

plus500
 


Australian

Acuvax Limited is an Australia-based holding company. The Company is engaged in the research and development of cancer therapies and virus and vaccine development. The Company is engaged in oncology drug research and development in two geographical segments: Australia and the United States. As of June 30, 2010, Acuvax had a 28% ownership in Hawaii Biotech Inc. (HBI). The principal activity of HBI is the development of preventative or prophylactic vaccines for infectious diseases, such as West Nile virus and dengue fever. The Company’s wholly owned subsidiaries include ACT (USA), Inc., Inqbate Pty Ltd and AL Holdings, Inc. 

http://www.acuvax.com.au/
Address
320 Adelaide Street GPO Box 111
Brisbane, QLD 4001
Australia
+61-07-30109442 (Phone)
+61-07-30109001 (Fax)
 
 
 
 
 
 
 

 


 
 
 
 
Copyright  2012   Ernstrade.com